Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Yonsei Medical Journal|April 8, 1998
Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progressionN C Yoo, H C Chung, H C Chung, et al.
Breast Cancer Research and Treatment|August 7, 1998
Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patientsH C Chung, S Y Rha, J O Park, et al.
British Journal of Cancer|August 31, 2013
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumoursH K Ahn, J Y Choi, K-M Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinomaJ Lee, W K Kang, J M Kwon, et al.
American Journal of Clinical Oncology|November 5, 1997
Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancerJ O Park, H C Chung, J Y Cho, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 6, 2022
A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal CancerH Jo, M-S Lee, Y-P Lee, et al.
American Journal of Clinical Oncology|February 24, 2001
Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancerJ B Ahn, W K Ko, J G Lee, et al.
British Journal of Cancer|May 5, 2005
Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancerS T Kim, W K Kang, J H Kang, et al.
British Journal of Cancer|June 10, 2004
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancerS-H Lee, W K Kang, J Park, et al.
Cancer Research and Treatment|December 19, 2015
A Phase II Study of Genexol(R) (paclitaxel) in Metastatic Breast CancerJ Y Jung, H C Jeong, S S Yoon, et al.
Pageof 6